Royal Philips, a leading health technology company, today announced the launch of the Philips IQon Spectral CT in Canada.
Royal Philips (NYSE:PHG, AEX:PHIA), a leading health technology company, today announced the launch of the Philips IQon Spectral CT in Canada. The Philips IQon Spectral CT is the world’s first and only spectral detector CT, designed specifically for spectral imaging. It delivers on-demand colour quantification and the ability to characterize structures simply and at a low dose.
IQon Spectral CT provides multiple layers of retrospective,
diagnostic data in a single, low-dose scan with seamless integration
into existing hospital system protocols. It can provide sufficient
information with only one scan to help clinicians make fast, confident
diagnoses, driving improved clinical and economic outcomes.
The IQon Spectral CT adds spectral resolution to traditional CT scanning
through a new dual-layer spectral detector. It identifies photons of
high energy and low energy simultaneously, allowing not only the view of
anatomy, but also uses colour to characterize the material content of
“The Philips IQon Spectral CT is further proof of our commitment of
delivering meaningful innovation,” said Iain Burns, President and CEO,
Philips Canada. “Today’s patient centered healthcare environment
requires the ability to enable ‘first-time’ right testing and
diagnostics. With just one scan, the new Philips IQon Spectral CT can
provide clinicians with the information required to help them make
confident diagnoses quickly.’’
The Philips IQon Spectral CT was recently used to scan the tail of Trix,
a T-Rex dinosaur who was discovered in Montana, USA in 2013 and was
purchased by the Naturalis museum and transported to the Netherlands in
August 23, 2016. Click here
to learn more.
Philips IQon Spectral CT and the full suite of Philips advanced imaging
solutions will be showcased at the 2016
Radiological Society of North America Annual Meeting (RSNA),
beginning November 27 through December 1 at McCormick Place in Chicago.
For more information on Philips’ presence at the 2016 RSNA Annual
Meeting, visit www.philips.com/rsna
and follow @PhilipsLiveFrom
updates throughout the event.
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is
a leading health technology company focused on improving people’s health
and enabling better outcomes across the health continuum from healthy
living and prevention, to diagnosis, treatment and home care. Philips
leverages advanced technology and deep clinical and consumer insights to
deliver integrated solutions. Headquartered in the Netherlands, the
company is a leader in diagnostic imaging, image-guided therapy, patient
monitoring and health informatics, as well as in consumer health and
home care. Philips’ health technology portfolio generated 2015 sales of
EUR 16.8 billion and employs approximately 70,000 employees with sales
and services in more than 100 countries. News about Philips can be found